市場調查報告書
商品編碼
1020430

血小板市場-增長、趨勢、COVID-19 的影響和預測(2021-2026)

Blood Platelets Market - Growth, Trends, COVID-19 Impact, and Forecast(2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,血小板市場預計將以 3% 或更高的複合年增長率增長。

COVID-19 大流行是影響血小板市場的前所未有的健康問題。由於 COVID-19 大流行的爆發,一些獻血者已經引入了獻血安全指南。例如,2020 年 7 月,世界衛生組織 (WHO) 引入了臨時指南,以在 COVID-19 大流行期間保持安全和充足的血液供應。此外,世界各國都面臨獻血者短缺的問題。例如,根據《柳葉刀血液學》上的一篇文章,加拿大的血液服務機構在 2020 年的獻血者百分比下降了 30%。因此,包括美國血液銀行家協會 (AABB)、美國血液中心 (ABC) 和美國紅十字會在內的多個組織於 2020 年 5 月發表聯合聲明,呼籲在大流行期間進行獻血。這樣的獻血工作可以滿足大流行期間醫療機構對血小板的需求。

這種市場增長是由於慢性血液相關疾病增加和手術增加等因素造成的。多年來,這些因素對血小板產生了巨大的需求,並且在不久的將來可能會持續下去。

隨著骨髓纖維化、血友病和血小板減少症等慢性血液相關疾病的患病率增加,對血小板的需求也在增加。根據 2019 年世界血友病聯盟年度世界調查,全球約 55 億人中有 324,648 人患有出血性疾病。據說肝病患者血小板減少症的風險也增加。例如,根據美國疾病控制與預防中心 (CDC) 2021 年的一篇文章,2018 年美國有 450 萬成年人被診斷出患有肝病。根據世界衛生組織 (WHO) 2021 年的一篇論文,肝硬化將成為 2020 年的主要死亡原因之一。因此,預計這些疾病患病率的增加將增加對造血幹細胞移植和通過輸血進行血小板治療的需求。

本報告對血小板市場進行了調查,並提供了市場概況以及應用、最終用戶、地區和進入市場的公司概況的趨勢。

目錄

第 1 章介紹

第 2 章調查方法

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 市場驅動力
    • 越來越多的外科手術
    • 慢性和血液相關疾病的患病率增加
  • 市場限制
    • 輸血過程中的高成本和感染風險
    • 缺乏獻血者
  • 波特五力分析

第 5 章市場細分

  • 按應用程序
    • 血小板功能障礙
    • 血友病
    • 血小板減少症
    • 周術期適應
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第 6 章競爭形勢

  • 公司簡介
    • The American National Red Cross
    • America's Blood Centers
    • Blood Centers of America
    • American Association of Blood Banks(AABB)
    • Canadian Blood Services
    • Cellphire, Inc.
    • The European Blood Alliance
    • DRK-Blutspendedienst Nord-Ost gemeinnutzige GmbH
    • OneBlood
    • Megakaryon Corporation
    • PlateletBio

第 7 章市場機會和趨勢

目錄
Product Code: 72135

The blood platelets market is projected to register a CAGR of more than 3% during the forecast period.

The COVID-19 pandemic is an unprecedented health concern that has impacted the blood platelets market. The onset of the COVID-19 pandemic has led several blood donation organizations to introduce safety guidelines pertaining to the donation of blood. For instance, in July 2020, the World Health Organization (WHO) introduced interim guidance on maintaining a safe and adequate blood supply during the COVID-19 pandemic. Moreover, countries worldwide are facing a shortage of blood donors. For instance, as per an article by The Lancet Hematology, the percentage of donors fell by 30% in 2020 at the Canadian Blood Services. Hence, several organizations, such as the American Association of Blood Banks (AABB), the American Blood Centers (ABC), and the American Red Cross, issued a joint statement in May 2020, which urged the public to donate blood during the pandemic. Such initiatives for blood donation may meet the demand for blood platelets by healthcare facilities in the pandemic.

The studied market growth can be largely attributed to the factors, such as the increasing prevalence of chronic blood-related disorders and the rising number of surgical procedures. These factors have created significant demand for blood platelets over the years and may continue to do so in the future.

With the increasing prevalence of chronic blood-related disorders, such as myelofibrosis, hemophilia, and thrombocytopenia, there is an increased demand for blood platelets. According to the 2019 Annual Global Survey by the World Federation of Hemophilia, approximately 324,648 people were identified with bleeding disorders out of 5.5 billion people, worldwide. Additionally, liver disorder patients are more often at risk of platelet reduction. For instance, as per a 2021 article by the Centers for Disease Control and Prevention (CDC), 4.5 million adults are diagnosed with liver disorders in the United States in 2018. Moreover, as per a 2021 article by the World Gastroenterology Organization (WHO), liver cirrhosis was one of the leading causes of death in 2020. Thus, the increasing prevalence of these disorders is projected to boost the demand for blood platelets treatment via hematopoietic stem cell transfer or transfusion methods.

The increasing number of surgical procedures, worldwide, is contributing to the increasing demand for blood platelets. Similarly, an increase in the number of orthopedic and cardiac surgeries is contributing to the rising demand for blood platelets in hospitals. Additionally, an increase in organ transplantations has boosted the demand for blood platelets. For instance, as per the Global Observatory on Donation and Transplantation data, 153,863 organs were transplanted annually in 2019, which was a 4.8% increase from 2018. Moreover, an increase in the number of trauma surgeries by impact forces, such as accidents, falls, sports, and crush injuries, is projected to boost the demand for blood platelets in the coming years. For instance, as per the 2021 statistics by the World Health Organization (WHO), each year, 20-50 million people suffer from non-fatal road injuries. Such a huge number indicates the rising need for blood platelets in these populations. Thus, all the factors mentioned above are currently augmenting the growth of the blood platelets market.

However, shortage of blood donors, risk of infections, and high cost of the surgeries are a few factors that restrain the market growth.

Key Market Trends

Platelet Function Disorders Segment is Expected to Witness a Significant CAGR Over the Forecast Period

Based on applications, platelet function disorders are predicted to witness significant growth. The major factors owing to the growth of the segment are the increasing prevalence of cancer. Chronic myelogenous leukemia and multiple myeloma cancers lead to the development of acquired platelet function disorders in some cancer patients. Therefore, cancer patients must undergo platelet transfusions frequently. As per the American Cancer Society estimates, approximately 34,920 people are likely to be diagnosed with multiple myeloma in 2021 in the United States. Additionally, as per the 2021 statistics by Cancer Research UK, incidence rates for myeloma are projected to increase by 11% in the United Kingdom between 2014 and 2035. Such numbers indicate the rising demand for platelet transfusion in the treatment of cancer patients. Moreover, chronic platelet function disorders contribute to the increasing demand for platelet transfusion. Thus, the administration of platelets in such patients is frequently performed in order to mitigate complications, including RBC requirements, surgical blood loss, and reoperation for bleeding. Thus, due to the factors mentioned above, the segment is anticipated to grow significantly over the forecast period.

North America Accounted for the Largest Share in the Global Market

In North America, the United States held a major share of the blood platelets market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. This is majorly attributed to the factors, such as the presence of several organizations engaged in the distribution of blood components. Moreover, these organizations in the region are engaged in increasing awareness regarding the importance of blood donation that is increasing the number of blood donors in the region. For instance, according to the 2020 statistics by the Centers for Disease Control and Prevention (CDC), presently, there are more than 13.2 million blood donors in the United States. Additionally, the number of platelet transfusions in the region has boosted the demand for blood platelets. For instance, as per the 2021 statistics by The American National Red Cross, approximately 21 million blood components are transfused each year in the United States. Thus, in view of the factors mentioned above, the blood platelets market is anticipated to grow significantly over the forecast period in North America.

Competitive Landscape

The blood platelets market is moderately competitive, and a few companies are currently dominating the market. These companies include Blood Centers of America, the American National Red Cross, Canadian Blood Services, Cellphire Inc., and PlateletBio, among others. The competition in the market is majorly based on the provision of blood components by these companies. Additionally, key players have been involved in organizing blood donation drives, campaigns, blood supply services to meet the demand from ambulatory surgical centers and hospitals with a focus on the expansion of blood platelet collection to secure the position in the global market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Number of Surgical Procedures
    • 4.2.2 Increasing Prevalence of Chronic and Blood-related Disorders
  • 4.3 Market Restraints
    • 4.3.1 High Cost and Risk of Infections in Transfusion Procedure
    • 4.3.2 Shortage of Blood Donors
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Applications
    • 5.1.1 Platelet Function Disorders
    • 5.1.2 Hemophilia
    • 5.1.3 Thrombocytopenia
    • 5.1.4 Perioperative Indications
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 The American National Red Cross
    • 6.1.2 America's Blood Centers
    • 6.1.3 Blood Centers of America
    • 6.1.4 American Association of Blood Banks (AABB)
    • 6.1.5 Canadian Blood Services
    • 6.1.6 Cellphire Inc.
    • 6.1.7 The European Blood Alliance
    • 6.1.8 DRK-Blutspendedienst Nord-Ost gemeinnutzige GmbH
    • 6.1.9 OneBlood
    • 6.1.10 Megakaryon Corporation
    • 6.1.11 PlateletBio

7 MARKET OPPORTUNITIES AND FUTURE TRENDS